EMEA-001604-PIP01-13-M03

Key facts

Invented name
Zepatier
Active substance
  • grazoprevir
  • elbasvir
Therapeutic area
Infectious diseases
Decision number
P/0255/2017
PIP number
EMEA-001604-PIP01-13-M03
Pharmaceutical form(s)
  • Film-coated tablet
  • Granules
Condition(s) / indication(s)
Treatment of chronic hepatitis C
Route(s) of administration
Oral use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.
Tel. +33 180464738
E-mail: pip.information@merck.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating